Cost Plus Drugs expands portfolio with Starjemza
Cost Plus Drugs Adds Starjemza to Portfolio Mark Cuban Cost Plus Drug Company announced the inclusion of Starjemza, a biosimilar medication, in its expanding lineup of affordable prescript…
Cost Plus Drugs Adds Starjemza to Portfolio Mark Cuban Cost Plus Drug Company announced the inclusion of Starjemza, a biosimilar medication, in its expanding lineup of affordable prescript…
AEW Collision Preview: November 1, 2025 Tonight is the Day of the Dead, and AEW Fright Night Collision takes place in Edinburg, Texas, ai…
The Cure at the Cinema: The Show Of A Lost World The Cure returns to French cinemas with The Show Of A Lost World, a unique 4K a…
Green Carbon Inc. Signs MOU with Living Roots for Biochar Fertilizer Development in Thailand Joint Initiative for Large-Scale Biochar Fe…
2025 AFLW All-Australian Squad Unveiled The AFLW All-Australian selection panel has revealed the initial 42-player squad competing for th…
Fed Cuts Rates for Second Straight Meeting On Wednesday, the Federal Reserve lowered its federal funds target range by 25 basis points to…
Climate Change Increased Intensity of Hurricane Melissa Impact on Jamaica Early on October 28th, Hurricane Melissa struck Jamaic…